comparemela.com
Home
Live Updates
Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the full year of 2023 - Adapting the company to create sustainable value : comparemela.com
Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the full year of 2023 - Adapting the company to create sustainable value
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year of 2023. Business highlights Sale
Related Keywords
Canada ,
Indonesia ,
New Zealand ,
Vietnam ,
Republic Of ,
South Korea ,
Cambodia ,
Allschwil ,
Switzerland General ,
Switzerland ,
Brunei ,
Malaysia ,
Japan ,
Mochida ,
Miyazaki ,
United States ,
Philippines ,
Thailand ,
Taiwan ,
Australia ,
China ,
Singapore ,
Laos ,
South Korean ,
America ,
Swiss ,
Nxera Pharma ,
Andrewc Weiss ,
Sosei Heptares ,
Johnson ,
Jean Paul Clozel ,
Idorsia Asia Pacific ,
Research Development ,
Head Of Investor Relations Corporate Communications ,
Day Center ,
Neurocrine Biosciences Inc ,
Swiss Exchange ,
Janssen Biotech Inc ,
Idorsia Ltd ,
Idorsia Pharmaceuticals Ltd ,
Paul Clozel ,
Chief Executive Officer ,
Chief Financial Officer ,
Nxera Deal ,
Neurocrine Biosciences ,
Sosei Deal ,
Mochida Pharmaceutical ,
Johnson Innovative Medicine ,
Janssen Biotech ,
Results Day Center ,
Business Report ,
Governance Report ,
Compensation Report ,
Financial Report ,
Sustainability Report ,
Annual General Meeting ,
Annual Report ,
North America ,
Vice President ,
Investor Relations ,
Pharmaceuticals Ltd ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.